CFDA Aims For Bigger Staff, More Power For Provinces As Cabinet-Level Agency
This article was originally published in PharmAsia News
Executive Summary
China FDA has outlined an ambitious plan to use its new cabinet-level status to streamline certifications, approvals and enforcement, and promised to focus on safety with beefed up staff levels.